Jacc. Cardiovascular Interventions
-
Publication Venue For
- Evaluating the Diagnostic Performance of Noninvasive Testing and the Perils of Inclusion Bias.. 13:656-657. 2020
- Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion.. 12:709-717. 2019
- Chronological Age Is Just a Number When it Comes to Percutaneous Coronary Intervention: Why Frailty May Matter More.. 11:1883-1884. 2018
- Hybrid Closure of Apical Post-Infarct Septal Defect: Externalizing an Occluder and Excluding the Right Ventricle.. 11:e59-e61. 2018
- Contemporary Patterns of Early Coronary Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry. 11:369-380. 2018
- Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention The ROCKET AF Trial. 9:1694-1702. 2016
- Correction. 9:1522-1522. 2016
- Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.. 9:1036-1046. 2016
- A Bigger Look Into the "Therapeutic Window" of Platelet Reactivity to Adenosine Diphosphate.. 8:1988-1989. 2015
- Proficiency With Vascular Access: Don't Rob Peter to Pay Paul.. 8:1865-1867. 2015
- Approaching the post-femoral era for coronary angiography and intervention.. 8:524-526. 2015
- Middle-of-the-night percutaneous coronary intervention and its association with percutaneous coronary intervention outcomes performed the following day: an analysis from the National Cardiovascular Data Registry.. 8:49-56. 2015
- The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings.. 8:10-16. 2015
- Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgery.. 7:981-987. 2014
- Uncovering the shroud on antiplatelet therapy for patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.. 7:613-614. 2014
- Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.. 7:471-481. 2014
- Erratum: Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients. (JACC: Cardiovascular Interventions (2012) 5 (958-65)). 5:1192. 2012
- Closed-chest transthoracic magnetic resonance imaging-guided ventricular septal defect closure in swine.. 4:1326-1334. 2011
- Direct percutaneous left ventricular access and port closure: pre-clinical feasibility.. 4:1318-1325. 2011
- Reply. 4:1252. 2011
- Reply. 4:1151-1152. 2011
- Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.. 4:381-391. 2011
- Reply. 4:468-469. 2011
- Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.. 3:731-741. 2010
- Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.. 2:917-924. 2009
- 100.45 Transradial Versus Transfemoral Access for Coronary Angiography and Intervention in Patients With Previous History of Coronary Artery Bypass Surgery 2019
- Transradial Coronary Intervention (TCI) Using 5-Fr Versus 6-Fr Guiding Catheters in the Setting of Acute Coronary Syndrome (ACS) 2018
- CRT-800.53 Association Between Preexisting Valvular Heart Disease and Takotsubo Cardiomyopathy among Hospitalized Patients in the United States 2017